XML 242 R42.htm IDEA: XBRL DOCUMENT v3.20.2
EQUITY AND EARNINGS PER SHARE (Tables)
 6 Months Ended
Jun. 30, 2020
Equity and Earnings Per Share [Abstract]  
Schedule of ATM Program Activity
The following table summarizes the Company’s ATM Program activity: 
Quarter EndedNumber of Common sharesAverage price per shareGross ProceedsFeesNet Proceeds
March 31, 2020(A)
97,394  $17.06  $1,662  $12  $1,650  
June 30, 2020—  $—  $—  $—  $—  
Schedule of Preferred Shares
The table below summarizes Preferred Shares:
Dividends Declared per Share
SeriesNumber of SharesLiquidation PreferenceIssuance DiscountCarrying ValueThree Months Ended
June 30, 2020		Six Months Ended
June 30, 2020
Fixed-to-floating rate cumulative redeemable preferred:
Preferred Series A, 7.50% Issued July 2019
6,210  $155,250  3.15 %$150,026  $0.47  $0.94  
Preferred Series B, 7.125% Issued August 2019
11,300  282,500  3.15 %273,418  $0.45  $0.89  
Preferred Series C, 6.375% Issued February 2020
16,100  402,500  3.15 %389,548  $0.40  $0.80  
Total33,610  $840,250  $812,992  
Schedule of Dividends Declared
Common dividends have been declared as follows:
Per Share
Declaration DatePayment DateQuarterly DividendTotal Amounts Distributed (millions)
March 31, 2020
April 2020
$0.05  $20.8  
June 22, 2020
July 2020
$0.10  $—  
Schedule of Warrants
The table below summarizes the 2020 Warrants at June 30, 2020:
Number of Warrants
(in millions)		Weighted Average Exercise Price (per share)
December 31, 2019 outstanding warrants—  $—  
Granted43.4  6.91  
Exercised—  —  
Expired—  —  
June 30, 2020 outstanding warrants43.4  $6.91  
Summary of Outstanding Options
As of June 30, 2020, New Residential’s outstanding options were summarized as follows:
Held by the Manager10,860,706  
Issued to the Manager and subsequently assigned to certain of the Manager’s employees
3,560,949  
Issued to the independent directors7,000  
Total14,428,655  
The following table summarizes New Residential’s outstanding options as of June 30, 2020. The last sales price on the New York Stock Exchange for New Residential’s common stock in the quarter ended June 30, 2020 was $7.43 per share.
Recipient
Date of
Grant/
Exercise(A)
Number of Unexercised
Options		Options
Exercisable as of
June 30, 2020
Weighted
Average
Exercise
Price(B)
Intrinsic Value of Exercisable Options as of
June 30, 2020
(millions)
DirectorsVarious7,000  7,000  $13.57  $—  
Manager(C)
20171,130,916  1,130,916  13.95  —  
Manager(C)
20185,320,000  4,156,548  16.66  —  
Manager(C)
20196,351,000  3,057,700  16.15  —  
Manager(C)
20201,619,739  215,965  17.41  —  
Outstanding14,428,655  8,568,129  
 
(A)Options expire on the tenth anniversary from date of grant.
(B)The exercise prices are subject to adjustment in connection with return of capital dividends. A portion of New Residential’s 2018 dividends was deemed to be a return of capital and the exercise prices were adjusted accordingly.
(C)The Manager assigned certain of its options to its employees as follows:
        
Date of Grant to ManagerRange of Exercise
Prices		Total Unexercised
Inception to Date
2017$13.951,130,916  
2018$16.54 to $18.011,159,833  
2019$15.13 to $16.671,270,200  
Total3,560,949  
 
The following table summarizes activity in New Residential’s outstanding options:
AmountWeighted Average Exercise Price
December 31, 2019 outstanding options12,808,916  
Options granted1,619,739  $17.41  
Options exercised—  —  
Options expired unexercised—  —  
June 30, 2020 outstanding options14,428,655  See table above
Schedule of Basic and Diluted Earnings Per Share
The following table summarizes the basic and diluted earnings per share calculations:
Three Months Ended
June 30,		Six Months Ended
June 30,
2020201920202019
Net income (loss)$44,129  $(25,020) $(1,563,126) $130,892  
Noncontrolling interests in income of consolidated subsidiaries
38,640  6,923  22,478  17,241  
Dividends on preferred stock14,357  —  25,579  —  
Net income (loss) attributable to common stockholders
$(8,868) $(31,943) $(1,611,183) $113,651  
Basic weighted average shares of common stock outstanding
415,661,782  415,463,757  415,625,468  401,946,938  
Dilutive effect of stock options(A)
—  —  —  292,500  
Dilutive effect of common stock purchase warrants(A)
—  —  —  —  
Diluted weighted average shares of common stock outstanding
415,661,782  415,463,757  415,625,468  402,239,438  
Basic earnings per share attributable to common stockholders
$(0.02) $(0.08) $(3.88) $0.28  
Diluted earnings per share attributable to common stockholders
$(0.02) $(0.08) $(3.88) $0.28  

(A)Stock options and common stock purchase warrants that could potentially dilute basic earnings per share in the future were not included in the computation of diluted earnings per share for the periods where a loss has been recorded because they would have been anti-dilutive for the period presented.

The Company excluded the following weighted-average potential common shares from the calculation of diluted net income (loss) per share during the applicable periods because their inclusion would have been anti-dilutive:
Three Months Ended
June 30,		Six Months Ended
June 30,
2020201920202019
Stock options—  201,703  —  —  
Common stock purchase warrants641,708  —  3,419,938  —  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The Company excluded the following weighted-average potential common shares from the calculation of diluted net income (loss) per share during the applicable periods because their inclusion would have been anti-dilutive:
Three Months Ended
June 30,		Six Months Ended
June 30,
2020201920202019
Stock options—  201,703  —  —  
Common stock purchase warrants641,708  —  3,419,938  —